Unilateral Atrophic Kidney in a 45-Year-Old Woman
Exploring Nonsurgical Management Of Chronic Venous Insufficiency
Encompassing a variety of symptoms and clinical manifestations, chronic venous insufficiency (CVI) increases the risk of venous thrombotic events and comes with substantial limitations on quality of life. In a Clinical Practice paper published in The New England Journal of Medicine (NEJM), Drs. Eri Fukaya and Raghu Kolluri provide a comprehensive overview of the nonsurgical management of CVI, outlining the concept of functional and structural insufficiency, sharing insights for diagnosis, and explaining and providing evidence for various treatment strategies.1
As summarized in NEJM, CVI is primarily caused by venous hypertension, which can be structural (venous reflux or obstruction) or functional (elevated central venous pressure, dependent edema, weak calf muscle, or obesity) in nature, or both. Diagnosis is based on both the patient history and the physical examination, as well as duplex ultrasound evaluation for assessing for structural causes.
Importantly, understanding and addressing the specific pathologic process of venous hypertension is crucial for both guiding appropriate therapy and having clinical improvement. Conservative or interventional/surgical treatment should be aimed at reducing symptoms, rather than physical exam or ultrasound alone.
In an interview with Endovascular Today, the paper's authors expand on these diagnosis and management discussions and reflect on the potential impact of this NEJM publication for both nonvascular and vascular physicians.
What are the main misconceptions or myths surrounding CVI and its management? What are the real-world ramifications?We believe there are several common misunderstandings about CVI in the general medical community.
These misconceptions can cause delays in care, and additionally, some clinicians believe that invasive procedures are always necessary and disregard effective conservative treatments. CVI is also mistakenly seen as limited to the elderly or solely genetic, ignoring its prevalence in younger individuals and the influence of other factors such as obesity and central venous hypertension. These misconceptions, along with the overemphasis on interventions, result in inconsistent care that ranges from undertreatment to excessive and unnecessary procedures, inflating health care costs and exposing patients to risks while neglecting underlying causes and delaying holistic, patient-centered management.
How does identifying the cause of venous hypertension impact your treatment decision?Identifying the cause of venolymphatic hypertension is essential for managing CVI, as treatment significantly varies depending on the underlying problem. For example, ablation of a refluxing saphenous vein may benefit a patient with a venous ulcer, but it is unlikely to help an obese patient with bilateral leg swelling caused by untreated right heart failure, obstructive sleep apnea, or phlebolymphedema. Effective CVI management, like any medical condition, requires a comprehensive plan focused on treating the patient as a whole—not merely addressing a refluxing superficial vein or an obstructed deep vein.
What is your ultimate goal when treating a patient with CVI, and how do you communicate that with the patient?My ultimate goal is to understand the patient's expectations and focus the initial discussion on those goals—whether it's ulcer healing, pain control, managing venous eczema, or improving appearance. Understanding patient goals and setting realistic expectations is paramount. This is communicated in simple terms, starting with, "What are you hoping to achieve from this visit, and what do you expect once your vein issues are treated?" These conversations are then documented in the clinic notes and often referred back to at follow-up visits to reinforce our mutually agreed-upon expectations.
What are the top unanswered questions when it comes to nonsurgical management of CVI? What do you think should be the next priorities for research?The understanding of the venolymphatic system's role in edema has evolved significantly over the past decade. Despite this progress, managing phlebolymphedema remains challenging for many practitioners, with treatment approaches varying widely. Continued research in this area is essential.
What is the potential impact of reaching the NEJM audience with the specifics regarding CVI? How do you hope to see it inform clinical practice and the conversations surrounding managing these patients, both beyond and within the vascular world?The NEJM is highly influential and has a broad reach among various medical specialties, including cardiovascular specialists, other internal medicine subspecialists, and primary care physicians. The last Clinical Practice article on CVI in NEJM was published in 2009 by Drs. Seshadri Raju and Peter Neglan.2 Since then, our understanding of venous disease has significantly advanced. A new Clinical Practice article on this topic serves several important purposes: (1) Increase awareness among primary care and nonvascular medical specialists, (2) update young vascular specialists, and (3) offer a comprehensive review for practicing venous specialists. The article aims to keep the patient at the center of care by introducing the concept of structural and functional venous hypertension, helping practitioners better understand and manage their patients' conditions. This should then contribute to improving patient care and outcomes in this widely prevalent condition.
Eri Fukaya, MD, PhD, FSVMClinical ProfessorDivision of Vascular Surgery, Vascular Medicine SectionStanford University School of MedicineStanford, Californiaefukaya@stanford.EduDisclosures: Consultant to Koya Medical and Medtronic.
Raghu Kolluri, MD, MS, RVT, MSVMSystem Medical Director, Vascular Medicine and Vascular Laboratories, OhioHealthAdjunct Clinical Professor of Medicine, Ohio University Heritage College of Osteopathic MedicinePresident, Syntropic Core LabColumbus, Ohiokolluri.Raghu@gmail.ComDisclosures: Consultant to Abbott, Auxetics, Diachii Sankyo, Koya Medical, Medtronic, Penumbra, Philips, and Surmodics.
What Are Your Top Tips and Tricks for Varicose Vein Treatment Planning?
With Sheila N. Blumberg, MD, MS; Ramona Gupta, MD, FSIR; and Kimberly Scherer, DO
Created with Sketch. Previous Article
The Shockwave Javelin Peripheral Intravascular Lithotripsy (IVL) Catheter
With JD Corl, MD, FACC, FSCAI, and Chris Paprzycki, MD, FACS
Next Article Created with Sketch.
Aortic Regurgitation - Physical Exam
In chronic aortic regurgitation, visible cardiac and arterial pulsations are common due to the large stroke volume, and the carotid pulse can commonly be seen.
The point of maximal impulse is displaced laterally and caudally due to LV dilation and hypertrophy. On auscultation, the typical murmur of aortic regurgitation is a soft, high-pitched, early diastolic decrescendo murmur heard best at the 3rd intercostal space on the left (Erb's point) on end expiration, with the patient sitting up and leaning forward.
This murmur is often difficult to distinguish from the Graham-Steele murmur of pulmonic insufficiency. If aortic root disease is the cause of the aortic regurgitation, the murmur will be heard best at the right upper sternal border and not at Erb's point. As aortic regurgitation worsens, the murmur becomes shorter in duration due to less time needed for LV and aortic pressure equalization.
In addition to the above murmur, a systolic ejection murmur may be present at the right upper sternal border simply due to the large stroke volume passing through the aortic valve with each LV systolic contraction. An early diastolic rumble may also be heard at the apex due to the regurgitant jet striking the anterior leaflet of the mitral valve causing it to vibrate. This murmur is termed the Austin-Flint murmur.
A widened pulse pressure is often present due to the high flow state, as previously described. When severe heart failure develops, the pulse pressure will decrease and the below listed peripheral signs of aortic regurgitation are lessened. A fourth heart sound develops when LV hypertrophy becomes severe and limits diastolic filling. A third heart sound is often present due to the increased early diastolic filling into a compliant, dilated LV.
Venous Insufficiency And Venous Ulcers
Content
What are the symptoms of a venous skin ulcer?
The first sign of a venous skin ulcer is skin that turns dark red or purple over the area where the blood is leaking out of the vein. The skin also may become thick, dry, and itchy.
Without treatment, an ulcer may form. The ulcer may be painful. You also may have swollen and achy legs.
If the wound becomes infected, the infection may cause an odor, and pus may drain from the wound. The area around the wound also may be more tender and red.
Call your doctor when you first notice the signs of a venous skin ulcer, because you may be able to prevent the ulcer from forming. If an ulcer has formed, get treatment right away, because new and smaller ulcers tend to heal faster than larger ones.
How is a venous skin ulcer treated?
The first step involves improving blood circulation. To do this, you can:
To help your ulcer heal, your doctor may also remove dead tissue from the wound (debridement).
After your ulcer has healed, continue to wear compression stockings. Take them off only when you bathe and sleep. Compression therapy helps your blood circulate and helps prevent other ulcers from forming.
If your ulcer doesn't heal within a few months, your doctor may advise other treatment, such as:
© 2016-2020 Healthwise, Incorporated.
Comments
Post a Comment